3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
5
Phase 2
3
Phase NA
2
Phase 4
2
Phase EARLY_PHASE1
1
Phase 3
1
Phase 1/2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
22
INDUSTRY
12
OTHER_GOV
1
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Prostatic Neoplasms
4
Hematologic Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Breast Neoplasms
2
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Solid Tumors
1
Solid Tumor
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Parotid Gland Neoplasms
1
Ovarian Neoplasms
1
Neoplasms
1
Multiple Myeloma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, B-Cell
1
Lymphoma
1
Locally Advanced Rectal Cancer
1
Liver Neoplasms
1
Leukemia, Plasma Cell
1
Immunoglobulin Light-chain Amyloidosis
1
Hematologic Diseases
1
EGFR Positive Non-small Cell Lung Cancer
1
Colorectal Neoplasms
1
Burkitt Lymphoma
1
Advanced Primary Liver Cancer
1
Interventions
avelumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase EARLY_PHASE1
×
OTHER_GOV
×
Lymphoma, B-Cell
×
Clear all
NCT03244176
2024-07-30
AvR-CHOP
Austin Health
Phase EARLY_PHASE1
Active not recruiting
28 enrolled